Eli Lilly (LLY) Hits High After Diabetes Drug Approval
Vložit
- čas přidán 20. 05. 2024
- Eli Lilly (LLY) is higher after Chinese regulators approve diabetes drug in China. Diane King Hall discusses this as Eli Lilly’s Phase 3 study of Crohn’s disease treatment achieves “meaningful improvements.” Eli Lilly hit a new all-time high today. Tune in to find out more about the stock market today.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - schwabnetwork.com/subscribe
Download the iOS app - apps.apple.com/us/app/schwab-...
Download the Amazon Fire Tv App - www.amazon.com/TD-Ameritrade-...
Watch on Sling - watch.sling.com/1/asset/19192...
Watch on Vizio - www.vizio.com/en/watchfreeplu...
Watch on DistroTV - www.distro.tv/live/schwab-net...
Follow us on X - / schwabnetwork
Follow us on Facebook - / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - schwabnetwork.com/about
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #elilily #healthcare